EGFR-IN-211 is a EGFR inhibitor with an IC50 of 0.131 µM. EGFR-IN-211 induces cell cycle arrest and apoptosis, and inhibits DNA synthesis and cell division. EGFR-IN-211 can be used in research related to cancers such as colorectal cancer and melanoma[1].
Molecular Weight:
634.56
Formula:
C29H21Cl2N7O2S2
Target:
Apoptosis,DNA/RNA Synthesis,EGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
